However, the third subtype, estrogen and progesterone receptor positive luminal-A breast cancer (ER+/PR+/HER2-) did not show increased intracellular cholesteryl esters or increased Ki-67 expression (de Gonzalo-Calvo et al., 2015). The gene discussed is PGR; the disease is breast carcinoma.